762 related articles for article (PubMed ID: 25326748)
21. Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease: A Patient-Level Pooled Analysis of 6,081 Patients.
Piccolo R; Pilgrim T; Heg D; Franzone A; Rat-Wirtzler J; Räber L; Silber S; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2015 Nov; 8(13):1657-66. PubMed ID: 26585615
[TBL] [Abstract][Full Text] [Related]
22. One-year follow-up of patients treated with new-generation polymer-based 38 mm everolimus-eluting stent: the P38 study.
Sgueglia GA; Belloni F; Summaria F; Conte M; Cortese B; Silva PL; Ricci R; Lioy E; Pucci E; Gaspardone A
Catheter Cardiovasc Interv; 2015 Feb; 85(2):218-24. PubMed ID: 24824088
[TBL] [Abstract][Full Text] [Related]
23. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
[TBL] [Abstract][Full Text] [Related]
24. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
[TBL] [Abstract][Full Text] [Related]
25. Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial.
Jensen LO; Thayssen P; Maeng M; Christiansen EH; Ravkilde J; Hansen KN; Kaltoft A; Tilsted HH; Madsen M; Lassen JF;
JACC Cardiovasc Interv; 2014 Aug; 7(8):840-8. PubMed ID: 25086842
[TBL] [Abstract][Full Text] [Related]
26. Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial.
Généreux P; Bettinger N; Redfors B; Lee AC; Kim CY; Lee MS; Shlofmitz RA; Moses JW; Stone GW; Chambers JW
Catheter Cardiovasc Interv; 2016 Sep; 88(3):369-77. PubMed ID: 27084293
[TBL] [Abstract][Full Text] [Related]
27. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
[TBL] [Abstract][Full Text] [Related]
28. Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study.
Cassese S; De Luca G; Villari B; Berti S; Bellone P; Alfieri A; Montinaro A; Quaranta G; Marraccini P; Piscione F;
Catheter Cardiovasc Interv; 2012 Sep; 80(3):408-16. PubMed ID: 21735531
[TBL] [Abstract][Full Text] [Related]
29. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
[TBL] [Abstract][Full Text] [Related]
30. Clinical Outcome After DK Crush Versus Culotte Stenting of Distal Left Main Bifurcation Lesions: The 3-Year Follow-Up Results of the DKCRUSH-III Study.
Chen SL; Xu B; Han YL; Sheiban I; Zhang JJ; Ye F; Kwan TW; Paiboon C; Zhou YJ; Lv SZ; Dangas GD; Xu YW; Wen SY; Hong L; Zhang RY; Wang HC; Jiang TM; Wang Y; Sansoto T; Chen F; Yuan ZY; Li WM; Leon MB
JACC Cardiovasc Interv; 2015 Aug; 8(10):1335-1342. PubMed ID: 26315736
[TBL] [Abstract][Full Text] [Related]
31. The long-term clinical outcome of T-stenting and small protrusion technique for coronary bifurcation lesions.
Naganuma T; Latib A; Basavarajaiah S; Chieffo A; Figini F; Carlino M; Montorfano M; Godino C; Ferrarello S; Hasegawa T; Kawaguchi M; Nakamura S; Colombo A
JACC Cardiovasc Interv; 2013 Jun; 6(6):554-61. PubMed ID: 23683737
[TBL] [Abstract][Full Text] [Related]
32. Outcomes following implantation of the Biolimus A9-eluting BioMatrix coronary stent: Primary analysis of the e-BioMatrix registry.
Urban P; Valdés M; Menown I; Eberli F; Alhaddad I; Hildick-Smith D; Iosseliani D; Roffi M; Oldroyd K; Kalloudi E; Eerdmans P; Berland J; Kleber FX;
Catheter Cardiovasc Interv; 2015 Dec; 86(7):1151-60. PubMed ID: 25683225
[TBL] [Abstract][Full Text] [Related]
33. Periprocedural myocardial infarction is associated with increased mortality in patients with coronary artery bifurcation lesions after implantation of a drug-eluting stent.
Chen SL; Zhang JJ; Ye F; Tian NL; Sheiban I; Jepson N; Paiboon C; Sansoto T; Kwan TW; Wen SY; Wang HC; Jiang TM; Wang Y; Chen LL; Qiu CG; Zhang YJ; Chen MX; De Maria A
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():696-705. PubMed ID: 25631678
[TBL] [Abstract][Full Text] [Related]
34. In-hospital and one year outcomes with drug-eluting versus bare metal stents in large native coronary arteries: a report from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
Gordon PC; Cohen DJ; Kleiman NS; Montgomery JA; Semder CA; Kennedy KF; Keyes MJ; Piana RN;
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E356-64. PubMed ID: 22511502
[TBL] [Abstract][Full Text] [Related]
35. Late thrombosis after double versus single drug-eluting stent in the treatment of coronary bifurcations: a meta-analysis of randomized and observational Studies.
Zimarino M; Corazzini A; Ricci F; Di Nicola M; De Caterina R
JACC Cardiovasc Interv; 2013 Jul; 6(7):687-95. PubMed ID: 23769650
[TBL] [Abstract][Full Text] [Related]
36. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
Almalla M; Schröder J; Pross V; Marx N; Hoffmann R
Catheter Cardiovasc Interv; 2014 May; 83(6):881-7. PubMed ID: 23765557
[TBL] [Abstract][Full Text] [Related]
37. Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization: From the WIN-DES Collaborative Patient-Level Pooled Analysis.
Giustino G; Baber U; Aquino M; Sartori S; Stone GW; Leon MB; Genereux P; Dangas GD; Chandrasekhar J; Kimura T; Salianski O; Stefanini GG; Steg PG; Windecker S; Wijns W; Serruys PW; Valgimigli M; Morice MC; Camenzind E; Weisz G; Smits PC; Kandzari DE; Galatius S; Von Birgelen C; Saporito R; Jeger RV; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Kastrati A; Chieffo A; Mehran R
JACC Cardiovasc Interv; 2016 Apr; 9(7):674-84. PubMed ID: 27056305
[TBL] [Abstract][Full Text] [Related]
38. A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study.
Han YL; Zhang L; Yang LX; Liu HL; Qu P; Li WM; Jiang TM; Li SM; Jing QM; Zhang QY; Xu B; Li Y; Gao RL
EuroIntervention; 2012 Nov; 8(7):815-22. PubMed ID: 23171802
[TBL] [Abstract][Full Text] [Related]
39. Six-year clinical outcomes of first-generation drug-eluting stents: a propensity-matched analysis.
Tarantini G; Barioli A; Facchin M; Frigo AC; Napodano M; Buja P; D'Amico G; Iliceto S; Isabella G
Coron Artery Dis; 2013 Aug; 24(5):440-8. PubMed ID: 23695366
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcomes of routine versus provisional T-stenting for de novo coronary bifurcation lesions: five-year results of the Bifurcations Bad Krozingen I study.
Ferenc M; Ayoub M; Büttner HJ; Gick M; Comberg T; Rothe J; Valina CM; Hochholzer W; Neumann FJ
EuroIntervention; 2015 Dec; 11(8):856-9. PubMed ID: 26696453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]